With 2019 underway, it’s critical for biomedical lIT leaders to prepare for the coming year. IT security, in the wake of cybercrime, is always evolving and the threats of last year may become archaic in the blink of an eye. Worse yet, being underprepared could lead to major data breaches for biomedical organizations, which are dangerous thanks to hackers being able to gain access to recent research before copyrights have been issued.
In previous years the biotech industry did not have a top-notch report card as far as cybersecurity was concerned – but that can change for your organization in 2019.
Data Breaches are Costing Biotech More
Data breaches that affect biotechnology companies are not just becoming more popular – they’re becoming even more expensive too. Last year, spending on annual data breaches rose 6.4 percent, and worldwide spending on cybercrime is expected to reach over $6 trillion by 2021.
This is in part from the increased amount, but also in the effectiveness of these attacks, leading to even more data loss and increased IT downtime and damaged reputation to customers. Cybersecurity is now, even more, pressing for mission-critical biotech operations where time is quite literally money — and lost or stolen information could take away important patents for life-saving medicines.
The Dangers Facing Biotechnology IT Security Are on the Rise
Even though a major security breach for a US-based biotechl operation hasn’t yet graced the news, it’s only a matter of time as the dangers of poor data security plague many biomedical organizations across the US.
Although nation-state attacks and politically-based hacks may make the best headlines on the news, the biggest danger is the folks doing their jobs. In many cases, cybersecurity best practices are lagging, meaning password management is poor and personal identification information can be easily obtained by a malicious third party and used for mal-intent. Additionally, poorly screened temporary or part-time employees have used their IT credentials to steal data or hardware, and pose a major threat to your organization.
Finally, the new technology your biomedical operation and its employees may rely on for personal and professional reasons could end up being the straw to break the camel’s back. Handheld devices like smartphones and tablets, and the growing connectivity of the internet of things, pose unique but serious threats to all major organizations — but even more so those without stringent cybersecurity practices in place. And with an estimated 20 billion devices expected to be connected to the IoT landscape by 2020, any security flaw can quickly snowball into a major challenge.
Handling Biotechnology IT Isn’t a One-Person Job
With so many new threats to protect against and tools and technologies to implement, it’s not easy to maintain successful and proper cybersecurity for an organization. That’s why a growing number of pharmaceutical organizations across the US are branching out and partnering with local IT consultancies to maintain their cybersecurity initiatives.
When you partner with a managed IT service provider like NENS, you’re preparing your organization for the cybersecurity threats of today and tomorrow. Our team of certified experts is trained, responsible, and reliable — and have extensive experience in every aspect of cybercrime prevention. Plus, we have a familiarity with the unique requirements and challenges many biotech organizations face and can ensure your cybersecurity is up to a gold standard for 2019.
Contact us today to learn about how we can work together to make a safer 2019 for your organization.